The incidence of secondary malignancies has been increasing, likely due to the improved survival rates of primary cancer patients. Advances in cancer treatments have allowed more individuals to live longer, thereby increasing the window of opportunity for the development of new cancers. The risk varies depending on the type of the initial cancer, the treatments used, and the patient's genetic and lifestyle factors.
